Novel mutations in NLGN3 causing autism spectrum disorder and cognitive impairment
- PMID: 31184401
- DOI: 10.1002/humu.23836
Novel mutations in NLGN3 causing autism spectrum disorder and cognitive impairment
Abstract
The X-linked NLGN3 gene, encoding a postsynaptic cell adhesion molecule, was involved in a nonsyndromic monogenic form of autism spectrum disorder (ASD) by the description of one unique missense variant, p.Arg451Cys (Jamain et al. 2003). We investigated here the pathogenicity of additional missense variants identified in two multiplex families with intellectual disability (ID) and ASD: c.1789C>T, p.Arg597Trp, previously reported by our group (Redin et al. 2014) and present in three affected cousins and c.1540C>T, p.Pro514Ser, identified in two affected brothers. Overexpression experiments in HEK293 and HeLa cell lines revealed that both variants affect the level of the mature NLGN3 protein, its localization at the plasma membrane and its presence as a cleaved form in the extracellular environment, even more drastically than what was reported for the initial p.Arg451Cys mutation. The variants also induced an unfolded protein response, probably due to the retention of immature NLGN3 proteins in the endoplasmic reticulum. In comparison, the c.1894A>G, p.Ala632Thr and c.1022T>C, p.Val341Ala variants, present in males from the general population, have no effect. Our report of two missense variants affecting the normal localization of NLGN3 in a total of five affected individuals reinforces the involvement of the NLGN3 gene in a neurodevelopmental disorder characterized by ID and ASD.
Keywords: autism spectrum disorder; intellectual disability; missense variants; neuroligin-3; unfolded protein response.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
Canonical versus non-canonical transsynaptic signaling of neuroligin 3 tunes development of sociality in mice.Nat Commun. 2021 Mar 23;12(1):1848. doi: 10.1038/s41467-021-22059-6. Nat Commun. 2021. PMID: 33758193 Free PMC article.
-
Analyses of the autism-associated neuroligin-3 R451C mutation in human neurons reveal a gain-of-function synaptic mechanism.Mol Psychiatry. 2024 Jun;29(6):1620-1635. doi: 10.1038/s41380-022-01834-x. Epub 2022 Oct 24. Mol Psychiatry. 2024. PMID: 36280753 Free PMC article.
-
Genetic background effects in Neuroligin-3 mutant mice: Minimal behavioral abnormalities on C57 background.Autism Res. 2018 Feb;11(2):234-244. doi: 10.1002/aur.1857. Epub 2017 Oct 13. Autism Res. 2018. PMID: 29028156 Free PMC article.
-
Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders.Brain Res Bull. 2017 Mar;129:82-90. doi: 10.1016/j.brainresbull.2016.10.006. Epub 2016 Oct 12. Brain Res Bull. 2017. PMID: 27743928 Review.
-
Evidence for a Contribution of the Nlgn3/Cyfip1/Fmr1 Pathway in the Pathophysiology of Autism Spectrum Disorders.Neuroscience. 2020 Oct 1;445:31-41. doi: 10.1016/j.neuroscience.2019.10.011. Epub 2019 Nov 6. Neuroscience. 2020. PMID: 31705895 Review.
Cited by
-
Diversity and Classification of Genetic Variations in Autism Spectrum Disorder.Int J Mol Sci. 2023 Nov 26;24(23):16768. doi: 10.3390/ijms242316768. Int J Mol Sci. 2023. PMID: 38069091 Free PMC article. Review.
-
Unraveling the Role of Neuroligin3 in Autism Spectrum Disorders: Pathophysiological Insights and Targeted Therapies.CNS Neurol Disord Drug Targets. 2024;23(7):801-811. doi: 10.2174/1871527323666230727102244. CNS Neurol Disord Drug Targets. 2024. PMID: 37497709 Review.
-
Neuroligins and Neurodevelopmental Disorders: X-Linked Genetics.Front Synaptic Neurosci. 2020 Aug 11;12:33. doi: 10.3389/fnsyn.2020.00033. eCollection 2020. Front Synaptic Neurosci. 2020. PMID: 32848696 Free PMC article. Review.
-
Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder.Genet Med. 2021 Nov;23(11):2150-2159. doi: 10.1038/s41436-021-01263-1. Epub 2021 Aug 3. Genet Med. 2021. PMID: 34345024
-
3-O-sulfated heparan sulfate interactors target synaptic adhesion molecules from neonatal mouse brain and inhibit neural activity and synaptogenesis in vitro.Sci Rep. 2020 Nov 5;10(1):19114. doi: 10.1038/s41598-020-76030-4. Sci Rep. 2020. PMID: 33154448 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- APP1041920/NHMRC/International
- APP1091593/NHMRC/International
- Agence Nationale de la Recherche/International
- 2012-33662/Fondation de France/International
- Association pour le Développement de la Neurogénétique/International
- Association Paul et Liba Mandel/International
- ANR-10-LABX-0030-INRT/Association APLM/International
- ANR-10-IDEX-0002-02/the Agence Nationale de la Recherche under the frame program Investissements d'Avenir/International
- APP1041920/Australian NHMRC/International
- APP1091593/Australian NHMRC/International
- "Association pour le Développement de la Neurogénétique" to Frédéric Laumonnier/International
LinkOut - more resources
Full Text Sources
Medical
